Comparative effectiveness of aspirin for symptomatic venous thromboembolism prophylaxis in patients undergoing total joint arthroplasty, a cohort study
Journal article
Sidhu, Verinder, Hawke, Helen, Churches, Tim, Naylor, Justine, Adie, Sam and Harris, Ian A.. (2023). Comparative effectiveness of aspirin for symptomatic venous thromboembolism prophylaxis in patients undergoing total joint arthroplasty, a cohort study. BMC Musculoskeletal Disorders. 24(1), pp. 1-8. https://doi.org/10.1186/s12891-023-06750-x
Authors | Sidhu, Verinder, Hawke, Helen, Churches, Tim, Naylor, Justine, Adie, Sam and Harris, Ian A. |
---|---|
Abstract | Background: This study compares the symptomatic 90-day venous thromboembolism (VTE) rates in patients receiving aspirin to patients receiving low-molecular weight heparin (LMWH) or direct oral anticoagulants (DOACs), after total hip (THA) and total knee arthroplasty (TKA). Methods: Data were collected from a multi-centre cohort study, including demographics, confounders and prophylaxis type (aspirin alone, LMWH alone, aspirin and LMWH, and DOACs). The primary outcome was symptomatic 90-day VTE. Secondary outcomes were major bleeding, joint related reoperation and mortality within 90 days. Data were analysed using logistic regression, the Student’s t and Fisher’s exact tests (unadjusted) and multivariable regression (adjusted). Results: There were 1867 eligible patients; 365 (20%) received aspirin alone, 762 (41%) LMWH alone, 482 (26%) LMWH and aspirin and 170 (9%) DOAC. The 90-day VTE rate was 2.7%; lowest in the aspirin group (1.6%), compared to 3.6% for LMWH, 2.3% for LMWH and aspirin and 2.4% for DOACs. After adjusted analysis, predictors of VTE were prophylaxis duration < 14 days (OR = 6.7, 95% CI 3.5–13.1, p < 0.001) and history of previous VTE (OR = 2.4, 95% CI 1.1–5.8, p = 0.05). There were no significant differences in the primary or secondary outcomes between prophylaxis groups. Conclusions: Aspirin may be suitable for VTE prophylaxis following THA and TKA. The comparatively low unadjusted 90-day VTE rate in the aspirin group may have been due to selective use in lower-risk patients. Trial Registration: This study was registered at ClinicalTrials.gov, trial number NCT01899443 (15/07/2013). |
Keywords | Venous thromboembolism; Arthroplasty; Aspirin; Low-molecular Weight Heparin; Novel oral anticoagulants |
Year | 01 Jan 2023 |
Journal | BMC Musculoskeletal Disorders |
Journal citation | 24 (1), pp. 1-8 |
Publisher | BioMed Central Ltd. |
ISSN | 1471-2474 |
Digital Object Identifier (DOI) | https://doi.org/10.1186/s12891-023-06750-x |
Web address (URL) | https://bmcmusculoskeletdisord.biomedcentral.com/articles/10.1186/s12891-023-06750-x |
Open access | Published as ‘gold’ (paid) open access |
Research or scholarly | Research |
Page range | 1-8 |
Publisher's version | License File Access Level Open |
Output status | Published |
Publication dates | |
03 Aug 2023 | |
Publication process dates | |
Accepted | 24 Jul 2023 |
Deposited | 12 Mar 2024 |
Additional information | © The Author(s) 2023. |
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. | |
Trial Registration: This study was registered at ClinicalTrials.gov, trial number NCT01899443 (15/07/2013) | |
Place of publication | United Kingdom |
https://acuresearchbank.acu.edu.au/item/9046z/comparative-effectiveness-of-aspirin-for-symptomatic-venous-thromboembolism-prophylaxis-in-patients-undergoing-total-joint-arthroplasty-a-cohort-study
Download files
Publisher's version
OA_Hawke_2023_Comparative_effectiveness_of_aspirin_for_symptomatic.pdf | |
License: CC BY 4.0 | |
File access level: Open |
27
total views20
total downloads2
views this month0
downloads this month